Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib

The HER family of receptor tyrosine kinases has been linked to deregulation of growth and proliferation for multiple types of cancer. Members have therefore become thefocus of many drug and immune-based therapy innovations. The targeted anti-cancer agent, lapatinib, is a small molecule inhibitor tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Showalter, Loral E., Oechsle, Crystal, Ghimirey, Nirmala, Steele, Chase, Czerniecki, Brian J., Koski, Gary K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338365/
https://www.ncbi.nlm.nih.gov/pubmed/30657766
http://dx.doi.org/10.1371/journal.pone.0210209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338365/
https://www.ncbi.nlm.nih.gov/pubmed/30657766
http://dx.doi.org/10.1371/journal.pone.0210209

Ejemplares similares